Argenx (ARGX)
(Delayed Data from NSDQ)
$499.67 USD
-16.51 (-3.20%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $499.41 -0.26 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth A Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 36% (88 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.32 | 1.35 | 9.99 |
Current Quarter Estimate | 0.08 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -1.25 | 0.12 | 54.84 |
Next Quarter Estimate | 0.36 | 7.81 | 63.00 |
Next Year Estimate | 4.99 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 90.70 | 15.80 | 15.67 |
Next Year | 1,139.58 | 10.10 | 11.34 |
Last 5 Years | -296.30 | 1.00 | 8.10 |
Next 5 Years | NA | 20.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 7.24 | 2.20 |
Price/Cash Flow (MRFY) | NA | 16.91 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -12.31% | -12.31% |
Return on Equity (TTM) | -7.33% | -15.05% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.